Second-hand smoke and chronic bronchitis in Taiwanese women: A health-care based study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Wu, Chia Fang ^a   Feng, Nan Hsiung ^b   Chong, Inn Wen ^a   Wu, Kuen Yuh ^c   Lee, Chien Hung ^a   Hwang, Jhi Jhu ^a   Huang, Chia Tsuan ^d   Lee, Chung Ying ^d   Chou, Shao Ting ^b   Christiani, David C ^e   Wu, Ming Tsang ^a,d,f  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC BRONCHITIS; FEMALE; HUMAN; INSURANCE; MALE; PASSIVE SMOKING; PATIENT ATTITUDE; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; SMOKING; SPIROMETRY; TAIWAN; WOMEN'S HEALTH;

ADULT; BRONCHITIS, CHRONIC; FEMALE; HUMANS; INSURANCE CLAIM REPORTING; MALE; NATIONAL HEALTH PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; RISK FACTORS; SMOKING; SPIROMETRY; TAIWAN; TOBACCO SMOKE POLLUTION; WOMEN'S HEALTH;

EID: 77649316974     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-44     Document Type: Article

References (42)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society, Am J Respir Crit Care Med 1995 152 5 Pt 2 77 S83 7582322
2. Global burden of COPD: systematic review and meta-analysis. RJ Halbert JL Natoli A Gano E Badamgarav AS Buist DM Mannino, Eur Respir J 2006 28 3 523 532 10.1183/09031936.06.00124605 16611654
3. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. CJ Murray AD Lopez, Lancet 1997 349 9064 1498 1504 10.1016/S0140-6736(96)07492-2 9167458
4. Global initiative for chronic obstructive lung disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Asia Pacific COPD Roundtable Group, Respirology 2005 10 1 9 17 10.1111/j.1440-1843.2005.00692.x 15691232
5. Department of Health, Health Statistics. Vital statistics Taipei, Taiwan: Department of Health, Executive Yuan, ROC II 2000 2008
6. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. KF Rabe S Hurd A Anzueto PJ Barnes SA Buist P Calverley Y Fukuchi C Jenkins R Rodriguez-Roisin C van Weel J Zielinski, Am J Respir Crit Care Med 2007 176 6 532 555 10.1164/rccm.200703- 456SO 17507545
7. Global burden of COPD: risk factors, prevalence, and future trends. DM Mannino AS Buist, Lancet 2007 370 9589 765 773 10.1016/S0140-6736(07)61380-4 17765526
8. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. RM Davis TE Novotny, Am Rev Respir Dis 1989 140 3 Pt 2 82 S84 2782765
9. Bureau of Tobacco and Alcohol Monopoly, Annual Report of Tobacco, Alcohol Consumption Investigation in Taiwan Area Taipei, Taiwan: Bureau of Tobacco and Alcohol Monopoly, Taiwan Provincial Government 1974 1996
10. Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking Taiwanese women. CH Lee YC Ko W Goggins JJ Huang MS Huang EL Kao HZ Wang, Int J Epidemiol 2000 29 2 224 231 10.1093/ije/29.2.224 10817117
11. Bureau of Health Promotion, Taiwan Tobacco Control Annual Report Taipei, Taiwan: Bureau of Health Promotion, Department of Health, ROC 2009
12. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BQ Liu R Peto ZM Chen J Boreham YP Wu JY Li TC Campbell JS Chen, BMJ 1998 317 7170 1411 1422 9822393
13. Tracers for assessing exposure to environmental tobacco smoke: what are they tracing? JM Daisey, Environ Health Perspect 1999 107 Suppl 2 319 327 10.2307/3434424 10350517
14. Effects of environmental tobacco smoke on the respiratory health of adults. MS Jaakkola JJ Jaakkola, Scand J Work Environ Health 2002 28 Suppl 2 52 70 12058803
15. The toxicology of environmental tobacco smoke. H Witschi JP Joad KE Pinkerton, Annu Rev Pharmacol Toxicol 1997 37 29 52 10.1146/annurev.pharmtox.37. 1.29 9131245
16. Alveolar macrophage recruitment and activation by chronic secondhand smoke exposure in mice. PG Woodruff A Ellwanger M Solon CJ Cambier KE Pinkerton LL Koth, COPD 2009 6 2 86 94 10.1080/15412550902751738 19378221
17. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. MD Eisner J Balmes PP Katz L Trupin EH Yelin PD Blanc, Environ Health 2005 4 1 7 15 10.1186/1476-069X-4-7 15890079
18. Directly measured secondhand smoke exposure and COPD health outcomes. MD Eisner J Balmes EH Yelin PP Katz SK Hammond N Benowitz PD Blanc, BMC Pulm Med 2006 6 12 22 10.1186/1471-2466-6-12 16756671
19. The impact of SHS exposure on health status and exacerbations among patients with COPD. MD Eisner C Iribarren EH Yelin S Sidney PP Katz G Sanchez PD Blanc, Int J Chron Obstruct Pulmon Dis 2009 4 1 169 176 19516915
20. Passive smoking exposure: a risk factor for chronic bronchitis and asthma in adults? K Radon K Busching J Heinrich HE Wichmann RA Jorres H Magnussen D Nowak, Chest 2002 122 3 1086 1090 10.1378/chest.122.3.1086 12226059
21. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. P Yin CQ Jiang KK Cheng TH Lam KH Lam MR Miller WS Zhang GN Thomas P Adab, Lancet 2007 370 9589 751 757 10.1016/S0140-6736(07) 61378-6 17765524
22. Environmental tobacco smoke and tobacco-related mortality in a prospective study of Californians, 1960-98. JE Enstrom GC Kabat, BMJ 2003 326 7398 1057 1067 10.1136/bmj.326.7398.1057 12750205
23. Characteristics of nonsmoking women exposed to spouses who smoke: epidemiologic study on environment and health in women from four Italian areas. F Forastiere S Mallone E Lo Presti S Baldacci F Pistelli M Simnoi A Scalera M Pedreschi R Pistelli G Corbo E Rapiti N Agabiti S Farchi S Basso L Chiaffi G Matteelli F Di Pede L Carrozzi G Viegi, Environ Health Perspect 2000 108 12 1171 1177 10.2307/3434830 11133398
24. Passive smoking and chronic obstructive lung disease. A Kalandidi D Trichopoulos A Hatzakis S Tzannes R Saracci, Lancet 1987 2 8571 1325 1326 10.1016/S0140-6736(87)91210-4 2890917
25. Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. PN Lee J Chamberlain MR Alderson, Br J Cancer 1986 54 1 97 105 3730259
26. Deaths from all causes in non-smokers who lived with smokers. DP Sandler GW Comstock KJ Helsing DL Shore, Am J Public Health 1989 79 2 163 167 10.2105/AJPH.79.2.163 2913834
27. Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. M Simoni S Baldacci R Puntoni F Pistelli S Farchi E Lo Presti R Pistelli G Corbo N Aqabiti S Basso G Matteelli F Di Pede L Carrozzi F Forastiere G Viegi, Respir Med 2007 101 3 531 538 10.1016/j.rmed.2006.06.021 16893638
28. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. P Vineis L Airoldi P Veglia L Olgiati R Pastorelli H Autrup A Dunning S Garte E Gormally P Hainaut C Malaveille G Matullo M Peluso K Overvad A Tjonneland F Clavel-Chapelon H Boeing V Krogh D Palli S Panico R Tumino B Bueno-De-Mesquita P Peeters G Berqulund G Hallmans R Saracci E Riboli, BMJ 2005 330 7486 277 282 10.1136/bmj.38327.648472.82 15681570
29. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. SL Wang JM Chiou CJ Chen CH Tseng WL Chou CC Wang TN Wu LW Chang, Environ Health Perspect 2003 111 2 155 159 12573898
30. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. JT Bernert Jr WE Turner JL Pirkle CS Sosnoff JR Akins MK Waldrep Q Ann TR Covey WE Whitfield EW Gunter BB Miller DG Patterson Jr LL Needham WH Hannon EJ Sampson, Clin Chem 1997 43 12 2281 2291 9439445
31. Pocked-sized spirometer for monitoring bronchial challenge procedures. H Keskinen P Piirila H Nordman M Nurminen, Clin Physiol 1996 16 6 633 643 10.1111/j.1475-097X.1996.tb00740.x 8937802
32. Pulmonary insufficiency; physiological classification, clinical methods of analysis, standard values in normal subjects. ED Baldwin A Cournand DW Richards Jr, Medicine 1948 27 3 243 278 18885031
33. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. E Berglund G Birath J Bjure G Grimby I Kjellmer L Sandqvist B Soderholm, Acta Med Scand 1963 173 185 192 13970718
34. Estimating the population attributable risk for multiple risk factors using case-control data. P Bruzzi SB Green DP Byar LA Brinton C Schairer, Am J Epidemiol 1985 122 5 904 914 4050778
35. Cotinine as a biomarker of environmental tobacco smoke exposure. NL Benowitz, Epidemiol Rev 1996 18 2 188 204 9021312
36. Reference interval and subject variation in excretion of urinary metabolites of nicotine from non-smoking healthy subjects in Denmark. AM Hansen AH Garde JM Christensen N Eller LE Knudsen R Heinrich-Ramm, Clin Chim Acta 2001 304 1-2 125 132 10.1016/S0009-8981(00)00415-0 11165207
37. Saliva cotinine levels in smokers and nonsmokers. JF Etter T Vu Duc TV Perneger, Am J Epidemiol 2000 151 3 251 258 10670549
38. Serum cotinine concentration and self-reported smoking during pregnancy. MA Klebanoff RJ Levine JD Clemens R DerSimonian DG Wilkins, Am J Epidemiol 1998 148 3 259 262 9690362
39. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. SJ Lewis NM Cherry R McL Niven PV Barber K Wilde AC Povey, Biomarkers 2003 8 3-4 218 228 10.1080/1354750031000120125 12944174
40. Public health methods - attributable risk as a link between causality and public health action. ME Northridge, Am J Public Health 1995 85 9 1202 1204 10.2105/AJPH.85.9.1202 7661224
41. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. A Lindberg A Bjerg-Backlund E Ronmark LG Larsson B Lundback, Respir Med 2006 100 2 264 272 10.1016/j.rmed.2005.04.029 15975774
42. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study. D Wilson R Adams S Appleton R Ruffin, Chest 2005 128 4 2035 2042 10.1378/chest.128.4.2035 16236852